Has Kyle Eash received payments from drug or device companies?

Yes. Drug and device makers reported $15,532 in general payments to Kyle Eash across 573 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kyle Eash did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kyle Eash come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kyle Eash

Dermatology · Wentzville, MONPI 1790072395

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.2% of the total across 573 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $4,481 and has fallen 71.1% since, to $1,295 in 2025.

$15,532in general payments, 2019–2025

Across 573 payments — averaging $27.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Amgen$1K
Johnson & Johnson$1K
E.r. Squibb & Sons, L.L.C.$1K
Janssen Scientific Affairs, LLC$1K
Novartis$1K
plus $8K from 23 others

What the payments were for

Food & beverage$15,41299%
Education$1201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	101	$2,092
Amgen	47	$1,318
Johnson & Johnson	64	$1,315
E.r. Squibb & Sons, L.L.C.	27	$1,140
Janssen Scientific Affairs, LLC	11	$1,136
Novartis	54	$1,012
Lilly USA, LLC	46	$908
Pfizer	41	$799
Dermavant Sciences, Inc.	26	$797
Incyte Corporation	20	$673
Regeneron Healthcare Solutions, Inc.	14	$636
Sun Pharmaceutical Industries Inc.	29	$545
Galderma Laboratories, L.p.	19	$541
UCB, Inc.	22	$504
Organogenesis Inc.	3	$370
Sanofi	17	$358
Arcutis Biotherapeutics, Inc.	2	$232
Boehringer Ingelheim	2	$232
Kerecis Limited	2	$210
Genentech USA, Inc.	6	$188
Organon	1	$120
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$109
LEO Pharma Inc.	6	$105
Almirall LLC	3	$52
Mission Pharmacal Company	2	$41
EPI Health, LLC	2	$32
Journey Medical Corporation	2	$29
Sandoz	1	$21
Fresenius Kabi USA, LLC	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,532 in reported general payments places this provider in the 85th percentile of 263 dermatology providers in Missouri.

See all dermatology providers in Missouri →

Medicare billing

Part B allowed, 2024

$60,742

Medicare patients

263

Services billed

1,352

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clobetasol Propionate	68	$2,265
Ketoconazole	161	$2,126
Metronidazole	41	$1,982
Tacrolimus	11	$857
Triamcinolone Acetonide	105	$815
Gentamicin Sulfate	19	$643
Mupirocin	45	$604
Clindamycin Phosphate	20	$602
Hydrocortisone	60	$523
Minocycline Hcl	16	$460
Doxycycline Hyclate	33	$443
Cephalexin	30	$301
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc	12	$282
Hydroxyzine Hcl	19	$204
Prednisone	25	$58

Paid to pharmacies, not to this prescriber.

Other dermatology in Wentzville

Stacy BlumWentzville$19K
Lindsey GraviettWentzville$13K
Jaeyoung YoonWentzville$12K
Brian KimSaint Louis$861K
Elaine SiegfriedSaint Louis$856K
Craig LeonardiSaint Louis$569K
Jonathan CleaverKirksville$483K
Mary GeorgeSaint Louis$400K
David CleaverKirksville$371K
Christy RaineyBranson$328K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →